Literature DB >> 1737540

Lipid status after pancreas-kidney transplantation.

J L Larsen1, R J Stratta, C F Ozaki, R J Taylor, S A Miller, W C Duckworth.   

Abstract

OBJECTIVE: This study was performed to determine the net effects of euglycemia, resolution of renal failure, immunosuppressant drugs, and hyperinsulinemia on fasting lipid profiles of patients with renal failure and insulin-dependent diabetes mellitus (IDDM) after combined pancreas-kidney transplantation (PKT). RESEARCH DESIGN AND METHODS: Thirty subjects with IDDM received PKT between April 1989 and October 1990, and all were studied. Mean +/- SE age was 35.2 +/- 1.3 yr; 19 recipients were men, and 11 were women. All had a functioning pancreatic allograft post-PKT. Fasting lipid profiles including total cholesterol (C), triglyceride (TG), high-density lipoprotein cholesterol (HDL-chol), and C/HDL-chol were compared before and after PKT (38-555 days divided into groups: preoperation and 0-2, 3-8, and 9-19 mo).
RESULTS: Significant hyperlipidemia was observed preoperatively (means +/- SE): C, 5.92 +/- 0.27 mM; HDL-chol, 1.07 +/- 0.09 mM; TG, 5.85 +/- 0.56 mM; and C/HDL-chol, 6.49 +/- 0.83. All lipids and C/HDL-chol dropped immediately after PKT (0-2 mo vs. preoperation, all P less than 0.01, except HDL-chol). After this immediate postoperative period, C, HDL-chol, and TG stabilized at new concentrations. C (5.44 +/- 0.22 mM) and TG (4.54 +/- 0.48 mM) levels were less than preoperation (not statistically significant and P less than 0.05, respectively). HDL-chol was greater than preoperative values (1.29 +/- 0.06 mM, P less than 0.05). C/HDL-chol dropped after PKT (0-2 mo, 4.85 +/- 0.18, P less than 0.01) and continued to decrease throughout the observation period (3-8 mo, 4.42 +/- 0.23; 9-19 mo, 4.23 +/- 0.23; both P less than 0.01 vs. preoperation). There was no statistical difference between lipid concentrations in male and female subjects.
CONCLUSIONS: The lipid status of subjects with IDDM and renal failure was abnormal before PKT and once lipid concentrations stabilized after PKT (greater than 2 mo), HDL-chol was higher and TG and C/HDL-chol levels were significantly lower than preoperative values. If these changes are sustained, risk of future cardiovascular disease in this group of patients might be significantly reduced.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1737540     DOI: 10.2337/diacare.15.1.35

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  5 in total

Review 1.  Syndrome X following renal transplantation.

Authors:  S B Nicholas
Journal:  Curr Hypertens Rep       Date:  2001-04       Impact factor: 5.369

Review 2.  Pancreas transplantation.

Authors:  R J Stratta; R J Taylor; J L Larsen; K Cushing
Journal:  Int J Pancreatol       Date:  1995-02

3.  Near normalization of metabolic and functional features of the central nervous system in type 1 diabetic patients with end-stage renal disease after kidney-pancreas transplantation.

Authors:  Paolo Fiorina; Paolo Vezzulli; Roberto Bassi; Chiara Gremizzi; Monica Falautano; Francesca D'Addio; Andrea Vergani; Lola Chabtini; Erica Altamura; Alessandra Mello; Rossana Caldara; Marina Scavini; Giuseppe Magnani; Andrea Falini; Antonio Secchi
Journal:  Diabetes Care       Date:  2011-12-21       Impact factor: 19.112

Review 4.  Diabetes and other endocrine-metabolic abnormalities in the long-term follow-up of pancreas transplantation.

Authors:  Marcio W Lauria; Antonio Ribeiro-Oliveira
Journal:  Clin Diabetes Endocrinol       Date:  2016-07-15

5.  Pancreas Retransplant After Pancreas Graft Failure in Simultaneous Pancreas-kidney Transplants Is Associated With Better Kidney Graft Survival.

Authors:  Sandesh Parajuli; Annamalai Arunachalam; Kurtis J Swanson; Fahad Aziz; Neetika Garg; Natalie Bath; Robert R Redfield; Dixon Kaufman; Arjang Djamali; Jon Odorico; Didier A Mandelbrot
Journal:  Transplant Direct       Date:  2019-07-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.